MedPath

The Diabetes and Eye Health project: increasing eye examinations for adults newly diagnosed with type 2 diabetes.

Not Applicable
Completed
Conditions
Diabetes
Diabetic retinopathy
Public Health - Health promotion/education
Metabolic and Endocrine - Diabetes
Eye - Diseases / disorders of the eye
Registration Number
ACTRN12614001110673
Lead Sponsor
Deakin University (The Australian Centre for Behavioural Research in Diabetes)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
721
Inclusion Criteria

1. Diagnosed with type 2 diabetes in the past three years
2. Australian residents
3. Able to read English
4. Registered with the National Diabetes Services Scheme (NDSS)
5. One of either:
- young adult (aged 18-39 years), or
- live in rural/regional locations of Victoria, Australia

Exclusion Criteria

Other diabetes types (e.g. Type 1, gestational, MODY)
Impaired cognitive ability

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Outcome is increase/decrease in self-reported eye health examinations assessed via response to a single questionnaire item (Since you were diagnosed with diabetes, have you had your eye health checked?).<br><br>In order to minimise social desirability bias and any potential confounding influence of question-behaviour effect, the question will be embedded within a suite of standard self-management questions based on information already provided to all new NDSS registrants[Baseline and six months after randomisation]
Secondary Outcome Measures
NameTimeMethod
Outcome is increase/decrease in intention to seek eye health examinations assessed via summed response to three intention items designed specifically for this purpose. [Baseline and six months after randomisation];Outcome is increase/decrease in knowledge of modifiable risk factors associated with diabetic retinopathy assessed using a questionnaire designed specifically for this study.[Baseline and six months after randomisation]
© Copyright 2025. All Rights Reserved by MedPath